Central line associated bloodstream infections in hospitalized children in Greece before and after implementation of a prevention bundle
AbstractData on central line (CL) - associated bloodstream infections (CLABSIs) in neonates and children in Greece are limited. In this study we aimed to assess the epidemiology and microbiology of CLABSIs in children’s hospitals in Greece using an active surveillance system and to assess the impact of a central line bundle on the incidence of CLABSIs. The study was conducted by active surveillance for CLABSIs over an 18-month period (September 2012 – February 2014) in the two largest children’s hospitals in Greece. After six months of surveillance, a CLABSI prevention bundle was introduced. There were 4.07 infections per 1,000 CL days across all participating units in the baseline period. The infection rate during the intervention period decreased by 35% to 2.58 per 1,000 CL days (95% CI: 0.64 (0.55 – 0.75)). Stratified analysis by ward type revealed the highest baseline CLABSI rate for patients in paediatric intensive care units (16.67 per 1,000 CL days), where the greatest reduction (50%) in the CLABSI rate was detected after the intervention. Overall, 48 (60%) of the isolated pathogens were Gram negative, where 4 (8.3%) were found to be resistant to carbapenems and 22 (45.8%) to one or more of third generation cephalosporins. Implementation of the prevention bundle produced a significant reduction of the CLABSIs in the Greek paediatric hospitals. The high CLABSI rates and the levels of antimicrobial resistance of pathogens identified highlight the importance of establishing antimicrobial stewardship and active surveillance programs in Greece, a country with high rates of healthcare-associated infections during a period of financial crisis.
Copyright conditions: Copyright on any research article in the International Journal of Infection Control (IJIC) is retained by the author(s). Authors grant IJIC permission to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified. IJIC conforms to the Creative Commons Attribution License (http://creativecommons.org) as terms and conditions of publishing research articles. In summary, anyone is free: • to copy, distribute, and display the work; • to make derivative works; • to make commercial use of the work; as long as: • the original author must be given credit; • for any reuse or distribution, it must be made clear to others what the license terms of this work are; • any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above. Authors' certification: In submitting a manuscript to IJIC, authors are requested to certify that: • They are authorized by their co-authors to enter into these arrangements. • They warrant, on behalf of themselves and their co-authors, that: o the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights; o they are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to IJIC are not in breach of any other obligation. If the law requires that the article be published in the public domain, they will notify IJIC at the time of submission; o the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy; o they have taken due care to ensure the integrity of the article.